Non-high-density lipoprotein cholesterol concentration is associated with the metabolic syndrome among us youth aged 12-19 years

Journal of Pediatrics

Volumn 158, Issue 2, 2011, Pages 201-207

  Li, Chaoyang ^a   Ford, Earl S ^a   McBride, Patrick E ^b   Kwiterovich, Peter O ^c   McCrindle, Brian W ^d   Gidding, Samuel S ^e  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIET RESTRICTION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; AGE DISTRIBUTION; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; METABOLIC SYNDROME X; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; ROC CURVE; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 78651513291     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.07.050     Document Type: Article

References (35)

1. M.G. Frontini, S.R. Srinivasan, J.H. Xu, R. Tang, M.G. Bond, and G. Berenson Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (the Bogalusa Heart Study) Am J Cardiol 100 2007 64 68
2. W.R. Farwell, H.D. Sesso, J.E. Buring, and J.M. Gaziano Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction Am J Cardiol 96 2005 1129 1134
3. J.G. Robinson, S. Wang, B.J. Smith, and T.A. Jacobson Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk J Am Coll Cardiol 53 2009 316 322
4. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
5. A.D. Sniderman, and M. Faraj Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome Curr Opin Lipidol 18 2007 633 637
6. S. Cook, P. Auinger, C. Li, and E.S. Ford Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002 J Pediatr 152 2008 165 170
7. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. Available from: http://www.cdc.gov/nchs/nhanes/htm. Accessed April 10, 2009.
8. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: body composition procedures manual. Available from: http://www.cdc.gov/nchs/data/nhanes/BC/pdf. Accessed September 27, 2008.
9. R.J. Kuczmarski, C.L. Ogden, S.S. Guo, L.M. Grummer Strawn, K.M. Flegal, and Z. Mei 2000 CDC growth charts for the United States: methods and development Vital Health Stat 11 2002 1 190
10. US Census Bureau. Current Population Survey (CPS) definitions and explanations. Available from: http://www.census.gov/population/www/cps/cpsdef/ html. Accessed April 10, 2009.
11. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr, and C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
12. E.S. Ford, C. Li, S. Cook, and H.K. Choi Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents Circulation 115 2007 2526 2532
13. K.G. Alberti, P. Zimmet, and J. Shaw Metabolic syndrome: a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabetes Med 23 2006 469 480
14. P. Zimmet, G. Alberti, F. Kaufman, N. Tajima, M. Silink, and S. Arslanian The metabolic syndrome in children and adolescents Lancet 369 2007 2059 2061
15. J.R. Fernandez, D.T. Redden, A. Pietrobelli, and D.B. Allison Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents J Pediatr 145 2004 439 444
16. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents Pediatrics 114 2004 555 576
17. D. Izrael, A. Battaglia, D. Hoaglin, and M. Battaglia Use of the ROC Curve and the Bootstrap in Comparing Weighted Logistic Regression Models 2002 SAS Institute Cary, NC p. 1-6
18. E.F. Schisterman, N.J. Perkins, A. Liu, and H. Bondell Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples Epidemiology 16 2005 73 81
19. G.S. Berenson, S.R. Srinivasan, W. Bao, W.P. Newman III, R.E. Tracy, and W.A. Wattigney Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study N Engl J Med 338 1998 1650 1656
20. H.C. McGill Jr, C.A. McMahan, A.W. Zieske, G.D. Sloop, J.V. Walcott, and D.A. Troxclair Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group Arterioscler Thromb Vasc Biol 20 2000 1998 2004
21. C.A. McMahan, S.S. Gidding, G.T. Malcom, R.E. Tracy, J.P. Strong, and H.C. McGill Jr Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis Pediatrics 118 2006 1447 1455
22. H.C. McGill Jr, C.A. McMahan, and S.S. Gidding Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study Circulation 117 2008 1216 1227
23. E.M. Haney, L.H. Huffman, C. Bougatsos, M. Freeman, R.D. Steiner, and H.D. Nelson Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force Pediatrics 120 2007 e189 e214
24. S.S. Gidding, N.J. Stone, L.C. Bookstein, P.M. Laskarzewski, and E.A. Stein Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents J Pediatr 133 1998 242 246
25. P.O. Kwiterovich Jr. The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review Am J Cardiol 86 2000 5L 10L
26. S.M. Grundy Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome Am J Cardiol 81 1998 18B 25B
27. S.R. Srinivasan, L. Myers, and G.S. Berenson Distribution and correlates of non-high-density lipoprotein cholesterol in children: the Bogalusa Heart Study Pediatrics 110 2002 e29
28. P.M. Ridker, N. Rifai, N.R. Cook, G. Bradwin, and J.E. Buring Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women JAMA 294 2005 326 333
29. P. McBride Triglycerides and risk for coronary artery disease Curr Atheroscler Rep 10 2008 386 390
30. C. Li, E.S. Ford, Y.X. Meng, A.H. Mokdad, and G.M. Reaven Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc Diabetol 7 2008 1 9
31. J.B. Ruige, W.J. Assendelft, J.M. Dekker, P.J. Kostense, R.J. Heine, and L.M. Bouter Insulin and risk of cardiovascular disease: a meta-analysis Circulation 97 1998 996 1001
32. N.J. Stone Nonpharmacologic management of mixed dyslipidemia associated with diabetes mellitus and the metabolic syndrome: a review of the evidence Am J Cardiol 102 2008 14L 18L
33. J. Huang, R. Parish, I. Mansi, H. Yu, E.M. Kennen, and T. Davis Non-high-density lipoprotein cholesterol in patients with metabolic syndrome J Investig Med 56 2008 931 936
34. F. Relimpio, F. Losada, A. Pumar, M.A. Mangas, F. Morales, and R. Astorga Relationships of apolipoprotein B(100) with the metabolic syndrome in type 2 diabetes mellitus Diabetes Res Clin Pract 57 2002 199 207
35. M. Kinoshita, H. Ohnishi, T. Maeda, N. Yoshimura, Y. Takeoka, and D. Yasuda Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome J Atheroscler Thromb 16 2009 517 522